Bridgebio Pharma Inc (BBIO)

EBITDA

-$141.56M

Quarterly · Period ending: · USD

BBIO logo

BBIO EBITDA

Latest reported-$141.56M
BBIO Quarterly EBITDA (-$42.40M → -$141.56M)
High-resolution chart · PNG

BBIO ebitda history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Bridgebio Pharma Inc EBITDA — Quarterly (USD)
Period endingEBITDA (USD)
-141,560,000
-112,554,000
-183,803,000
-173,345,000
-142,704,000
-126,183,000
-235,048,000
-139,655,000
-51,033,000
-11,093,000
-148,475,000
-157,543,000
-138,472,000
-120,978,000
-118,920,000
-118,723,000
19,302,000
-179,102,000
-135,622,000
-149,684,000
-87,749,000
-160,778,000
-123,628,000
-118,897,667
-123,965,000
-99,531,000
-80,737,000
-58,177,000
-72,393,000
-67,765,000
-47,962,000
-40,845,000
-35,455,000
-42,397,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.